Clinical Trials on Sleeping Sickness in Switzerland

Total 58 results

University Hospital Inselspital, Berne
Swiss National Science Foundation; Kantonsspital Aarau

Completed

Oxidative Stress in Hypobaric Hypoxia

Acute Mountain Sickness | Oxidative Stress | Hypobaric Hypoxia | Metabolomics

Switzerland
University of Lausanne Hospitals
Instituto Boliviano de Biologia de Altura; Universitad Major de S. Andres,...

Unknown

Chronic Mountain Sickness, Systemic Vascular Function (CMS)

Mountain Sickness | Chronic

Bolivia, Switzerland
University of Applied Sciences and Arts of Southern...
Vrije Universiteit Brussel; University of Portsmouth

Completed

The Psychophysiological Effect of Simulated and Terrestrial Altitude (Hypoxia)

Hypoxia | Altitude Sickness | Mountain Sickness | Hypoxia, Altitude | Altitude Hypoxia | Altitude

Switzerland
University of Zurich
University of Calgary

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Cerebral Autoregulation in Lowlanders

Effect of High Altitude

Switzerland
University of Zurich
University of Calgary

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Lung Water Content by Ultrasound

Effect of High Altitude

Switzerland
University of Zurich
University of Calgary

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Right Ventricular Function in Lowlanders

Effect of High Altitude

Switzerland
University of Zurich

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Postural Control in Lowlanders

Effect of High Altitude

Switzerland
University of Zurich
National Center of Cardiology and Internal Medicine named after academician...

Completed

Kyrgyz Asthma Rehabilitation at High Altitude

Effect of High Altitude

Switzerland
University of Zurich
Swiss Sportclinic Bern

Active, not recruiting

The Pre-acclimatization Augmented Extreme Altitude Expedition (PRAGMAX)

Perfusion; Complications | Altitude Hypoxia

Switzerland
University of Zurich
University of Calgary

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Nocturnal Breathing Pattern in Lowlanders

Effect of High Altitude

Switzerland
Clinique Romande de Readaptation

Completed

Effect of Isocaloric Ketogenic Diet on Physical Performance at High Altitude (ICKD)

Physical Activity | Ketogenic Dieting | Altitude Hypoxia

Switzerland
La Tour Hospital
Rive Droite SA

Unknown

In Vivo Clinical and Radiological Effects of Platelet-rich Plasma on Interstitial Supraspinatus Lesion: Randomized Study (PRP Randomized)

Platelet-rich Plasma (PRP) | Supraspinatis Interstitial Partial-thickness Tears

Switzerland
Balgrist University Hospital

Completed

Neuropathy of the Suprascapular Nerve Before and After Reconstruction of the Cuff (Neurospura)

Cuff Rotator Full Thickness Tear | Cuff Rotator Syndrome

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal Concentrations of Von Willebrand Factor (Will-Plate)

Bleeding

Switzerland
Association of Dutch Burn Centres
Seventh Framework Programme; Ernst Reichmann Tissue Biology Research Unit,...

Completed

A Study to Evaluate the Efficacy of an Acellular Dermal Template for the Treatment of Full Thickness Skin Defects

Full Thickness Skin Defects

Netherlands, Germany, Switzerland
University Hospital, Geneva

Completed

DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic (DAPHNE)

Anticoagulants and Bleeding Disorders

Switzerland
Walid HABRE
University Hospital, Geneva

Terminated

Dexamethasone and Postoperative Bleeding Following Tonsillectomy in Children (Blueberry)

Pain, Postoperative | Postoperative Nausea and Vomiting | Tonsillar Bleeding

Canada, Switzerland
University of Zurich
Luzerner Kantonsspital; Cantonal Hospital of St. Gallen

Unknown

TXA in the EMS on the Helicopter and the Ambulance (TXASRZREGA)

Bleeding

Switzerland
University Hospital, Geneva

Recruiting

Bleeding of Unknown Cause: a Swiss Case-control Study (SWISS-BUC)

Bleeding Disorder

Switzerland
The Medicines Company

Terminated

Phase II Study to Compare MDCO-2010 vs Placebo and Tranexamic Acid in Patients Undergoing Cardiac Surgery

Bleeding

Germany, Switzerland
University of Bern
WALA Heilmittel GmbH

Completed

Clinical Trial for Evaluating Sage-Based Mouthrinse

Satisfaction | Stomatitis, Denture | Tooth Staining | Stomal Bleeding

Switzerland
Centre Hospitalier Universitaire Vaudois

Completed

Prediction of Massive Transfusion in Trauma Patients (MTP)

Emergencies | Bleeding | Trauma Injury | Female | Blood Transfusion | Cohort Study | Prognosis | Adult | Male | Humans | Haemorrhagic Shock | Massive Transfusion | Massive Hemorrhage | Hospital Mortality | Bleeding Hemorrhage | Hemorrhage / Mortality | Models, Theoretical | Wounds and Injuries / Mortality

Switzerland
University Hospital, Geneva

Completed

Standardisation of Investigations of Mild Bleeding Disorders (MBD)

Hemorrhagic Disorders

Switzerland
University Hospital, Basel, Switzerland

Completed

Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy (RITE)

Venous Thrombosis | Bleeding | Varicose Veins | Thromboembolism

Switzerland
Biosensors Europe SA
European Cardiovascular Research Center

Completed

Leaders Free III: BioFreedom™ Clinical Trial

Myocardial Infarction | Mortality | Bleeding | Cardiac Death | Stent Thrombosis

France, Switzerland
Swiss Hemophilia Network

Recruiting

Swiss Hemophilia Registry

Hemophilia and Other Severe Bleeding Disorders

Switzerland
Novo Nordisk A/S

Completed

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

Congenital Bleeding Disorder | Haemophilia A

Spain, Germany, Switzerland, Italy, Israel
Bern University of Applied Sciences
University of Bern

Unknown

Perinatal Mental Health Care in Switzerland (MADRE)

Depression | Anxiety Disorders | Post Traumatic Stress Disorder | Psychosis | Substance Abuse | Panic Disorder | Behavior Disorders | Mental Disorder | Health Care Utilization | Adaptation Reaction | Health Care Seeking Behavior | Health Care Acceptability | Perinatal

Switzerland
Novo Nordisk A/S

Completed

Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation

Acquired Bleeding Disorder | Bleeding During/Following Surgery

Israel, Sweden, United Kingdom, Germany, Switzerland, France, Spain, Italy, Thailand, Denmark, United States, Poland, Finland, Singapore, Australia, Austria
University Hospital, Basel, Switzerland

Completed

Acquired Von Willebrand Syndrome in Severe Aortic Stenosis

Bleeding | Aortic Stenosis | Von Willebrand Disease

Switzerland
Novo Nordisk A/S

Terminated

Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding (CONTROL)

Trauma | Acquired Bleeding Disorder

Spain, Hong Kong, Germany, France, United Kingdom, Brazil, Italy, Hungary, Netherlands, United States, Switzerland, Czech Republic, Greece, South Africa
Biosensors Europe SA
European Cardiovascular Research Center

Unknown

A Randomized Clinical Evaluation of the BioFreedom™ Stent (Leaders Free)

Bleeding | Stable Angina | In-stent Coronary Artery Restenosis | Ischemic Heart Disease Silent | ST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial Infarction

Switzerland
Novo Nordisk A/S

Completed

Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury

Trauma | Acquired Bleeding Disorder

India, Spain, Canada, Finland, Germany, Israel, Italy, Netherlands, Singapore, Switzerland, Taiwan
Novo Nordisk A/S

Completed

Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency

Congenital Bleeding Disorder | Congenital FXIII Deficiency

United States, Israel, Austria, Spain, Switzerland, Germany, Canada, France, United Kingdom, Italy, Finland
Novo Nordisk A/S

Completed

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B (paradigm™7)

Congenital Bleeding Disorder | Haemophilia B

United States, Switzerland, Germany
Novo Nordisk A/S

Completed

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

Acquired Bleeding Disorder | Intracerebral Haemorrhage

Spain, Sweden, Singapore, Norway, Italy, Switzerland, Australia, Austria, Belgium, Canada, Denmark, Finland, Germany, Netherlands, United Kingdom
Biotest
PRA Health Sciences

Completed

Adjusted Fibrinogen Replacement Strategy (AdFIrst)

Bleeding Disorder | Hypofibrinogenemia; Acquired

Belgium, Czechia, Germany, Poland, Spain, Switzerland, United Kingdom
Novo Nordisk A/S

Completed

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B (Explorer 1)

Healthy | Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

Austria, Sweden, Spain, Switzerland, United Kingdom, Germany, Malaysia, Denmark, South Africa, Thailand, Italy
Novo Nordisk A/S

Completed

Observational Registry of the Treatment of Glanzmann's Thrombasthenia

Congenital Bleeding Disorder | Glanzmann's Disease

Spain, Bulgaria, Pakistan, Belgium, Germany, France, United Kingdom, Italy, Hungary, Netherlands, United States, Algeria, Austria, Sweden, Switzerland
Drahomir Aujesky
Bayer; The Ottawa Hospital; University of Bern; Leiden University Medical Center; Schweizerischer Nationalfonds

Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism (SAFE-SSPE)

Cardiovascular Diseases | Respiratory Tract Diseases | Lung Diseases | Embolism | Embolism and Thrombosis | Bleeding | Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding

Netherlands, Switzerland, Belgium, France, Canada
Novo Nordisk A/S

Completed

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A (pathfinder™1)

Congenital Bleeding Disorder | Haemophilia A

United States, Germany, Switzerland, United Kingdom, Italy, Japan, Turkey
Dr. Morten Hylander Møller
Rigshospitalet, Denmark; Copenhagen Trial Unit, Center for Clinical Intervention...

Completed

Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU)

Gastrointestinal Bleeding | Stress Ulcers

Denmark, Netherlands, Switzerland, Norway, Finland, United Kingdom
Cardiovascular Center Frankfurt

Completed

Peri-device Leakage Closure After LAAO

Stroke | Atrial Fibrillation | Bleeding | Leakage of Cardiac Device

Denmark, United States, Spain, Switzerland, Germany, Poland, United Kingdom
Novo Nordisk A/S

Completed

Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015

Congenital Bleeding Disorder | Haemophilia A

United States, Spain, Germany, Switzerland, Macedonia, The Former Yugoslav Republic of, Serbia, Taiwan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Israel, Russian Federation, Turkey, Lithuania, Poland, Japan, Latvia, Puerto...
ECRI bv
University of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaborators

Completed

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen (MASTER DAPT)

Coronary Artery Disease | PCI | High Bleeding Risk

Netherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
Novo Nordisk A/S

Completed

Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects (guardian™1)

Congenital Bleeding Disorder | Haemophilia A

United States, Spain, Germany, Switzerland, Serbia, Taiwan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Japan, Denmark, Hungary, Israel, Turkey, Russian Federation, Former Serbia and Montenegro
Novo Nordisk A/S

Completed

PROPACT: Retrospective Prophylaxis Patient Case Collection (PROPACT)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

Slovakia, Spain, Argentina, Germany, Croatia, Italy, Canada, United Kingdom, Ireland, Sweden, France, United States, Czech Republic, Switzerland
Novo Nordisk A/S

Completed

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A (pathfinder™2)

Congenital Bleeding Disorder | Haemophilia A

France, United States, Denmark, Netherlands, Sweden, Spain, Germany, Switzerland, Taiwan, Japan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Australia, Hungary, Israel, Turkey, Puerto Rico, Norway, Korea, Republic of, Bulgaria, Russian...
Novo Nordisk A/S

Completed

Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725 (mentor™2)

Congenital Bleeding Disorder | Congenital FXIII Deficiency

France, United States, Israel, Spain, Switzerland, Germany, Canada, Japan, United Kingdom, Italy, Finland, Austria
Novo Nordisk A/S

Completed

Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A (guardian™ 5)

Congenital Bleeding Disorder | Haemophilia A

Italy, Sweden, Netherlands, Austria, Spain, United States, Switzerland, Germany, France, Hungary, Greece, Slovenia, Czechia, Slovakia, Poland

Clinical Trials on Sleeping Sickness in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations